For histologically mild chronic hepatitis C, initial combination therapy compared with periodic liver biopsy should reduce the future risk for cirrhosis, prolong life, and be cost-effective.
Topics:
biopsy, hepatitis c, chronic, liver cirrhosis, hepatitis, antiviral agents, combined modality therapy, ...
Ann Intern Med. 2000;133(9):665-675. doi:10.7326/0003-4819-133-9-200011070-00008